The synthesis of novel glucagon-like peptide-1 receptor agonists presents a unique challenge for pharmaceutical scientists. Pharmaceutical companies sometimes require dedicated manufacturing capabilities to address https://tirzeptide.com/collections/fda-registered-peptides/products/bpc-158